ChemoCentryx, Inc. Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 1/28/2010
More...
|
BioMarin Pharmaceutical Inc. (BMRN): Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS 1/6/2010
More...
|
New Tool in Fight Against Autoimmune Diseases, Blood Cancers, The Scripps Research Institute Study 12/4/2009
More...
|
Amgen (AMGN) Highlights Data to be Presented at ASH Nplate(R) Data Documents Long-Term Safety and Efficacy for Treatment of Serious Chronic Autoimmune Disorder 11/30/2009
More...
|
A New Lead For Autoimmune Disease, Children's Hospital Boston Study 6/5/2009
More...
|
Varicella Zoster Infection Causes Severe Autoimmune Hepatitis, According to World Journal of Gastroenterology Report 3/3/2009
More...
|
Enzo Biochem (ENZ) Details Advances in Understanding the Role Of NKT Killer Cells in Autoimmunity and Cancer at Liver Conference 11/4/2008
More...
|
Alvine Pharmaceuticals, Inc. Reports Positive Results With ALV003 in Phase 1 Trial of Therapy in Development for Celiac Disease 10/29/2008
More...
|
Seattle Genetics, Inc. (SGEN) Presents on SGN-70 at American College of Rheumatology Meeting 10/28/2008
More...
|
Seattle Genetics, Inc. (SGEN) Initiates SGN-70 Phase I Clinical Trial 7/31/2008
More...
|
Symphogen A/S and Biovitrum AB have Initiated a Novel Treatment Study in Autoimmune Bleeding Disorder (ITP) Patients 7/16/2008
More...
|
National Institutes of Health (NIH) Scientists Discover Potential New Way to Block Inflammation in Autoimmune Disease 6/24/2008
More...
|
Tagging Cells Reveals The Immune System In Action, University of California, Los Angeles (UCLA) Study 6/10/2008
More...
|
New Hope For Rheumatoid Arthritis Sufferers: B Cells As Promising New Therapeutic Targets, University of Würzburg and University of Berlin Study 6/9/2008
More...
|
Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas 5/22/2008
More...
|
Sugar Linkage Could Lead To Better Treatment For Autoimmune Diseases, University of New Hampshire Study 5/15/2008
More...
|
How T Cell's Machinery Dials Down Autoimmunity, St. Jude Children's Research Hospital Study 5/13/2008
More...
|
Early Dementia Often Caused By Autoimmune Disorders, Mayo Clinic Study 4/16/2008
More...
|
Hadasit Ltd., Hadassah Medical Organization and Brigham and Women's Hospital Announce the Successful Phase I Study Results of a New Orally Administered Drug for Autoimmune Diseases 4/16/2008
More...
|
The Scripps Research Institute Study Finds T Cell Multiplication Unexpectedly Delayed After Infection; Lag May Provide Protection Against Autoimmune Reaction 4/11/2008
More...
|
Applied Data Research Release: Emerging Targets and Therapeutic Approaches Driving Activity in Autoimmune Disease Therapeutics 2/18/2008
More...
|
Pipex Pharmaceuticals (PPXP) Announces First Notice of Allowance for U.S. Patent Covering Uses of Low Potency Bioidentical Estrogens for the Treatment of Autoimmune Diseases of Women 1/31/2008
More...
|
Hadasit Ltd., Harvard Medical School, Hadassah Medical Organization and Brigham and Women's Hospital Collaborate for the First Time in a New Joint Venture to Develop a New Orally Administered Therapy for Autoimmune Diseases 1/22/2008
More...
|
Xencor Presents Findings on New Aspect of its Fc Technology Targeting Autoimmune Disease 12/7/2007
More...
|
LifeCycle Pharma Announces New Product Candidate; Initiates Phase I Clinical Trial for Sirolimus, an Immunosuppressant to Prevent Organ Rejection after Transplantation and for the Treatment of Certain Autoimmune Diseases 11/29/2007
More...
|
Pluristem Therapeutics' Proprietary PLX Cells Demonstrate Promising Potential in Treating Autoimmune Disorders 11/27/2007
More...
|
New Cancer Drugs Could Help in Autoimmune Disease 10/8/2007
More...
|
M. D. Anderson Cancer Center-Led Team Reports Possible Key to Autoimmune Disease 9/17/2007
More...
|
Dendritic Cells Stimulate Production of Immune-Repressing T Cells, Rockefeller University Study 9/17/2007
More...
|
Corgenix Medical Corporation (CONX) Reports New Clinical Data Correlating AtherOx™ Technology With Vascular Disease 7/10/2007
More...
|
Merrimack Pharmaceuticals Inc. Reduces Drug Discovery Time with SimBiology 7/9/2007
More...
|
La Jolla Institute for Allergy and Immunology Researchers Identify a Potential Role for Retinoic Acid in Autoimmune and Inflammatory Diseases 6/14/2007
More...
|
Sugar Supplement May Treat Immune Disease, University of California, Irvine Study Shows 6/8/2007
More...
|
TorreyPines Therapeutics, Inc. (TPTX) (Jobs) Transfers Intellectual Property and Compounds for Treating Autoimmune Diseases to CalciMedica 5/7/2007
More...
|
Xanthus Pharmaceuticals, Inc. Presents Novel Approach for Autoimmune Disease Reversal with Symadex 5/3/2007
More...
|
Cellerant Therapeutics, Inc. Reversed Autoimmune Disease in Lupus Mice with Transplant of Purified Donor Blood Stem Cells 4/23/2007
More...
|
Green Tea May Help Prevent Autoimmune Diseases, Medical College of Georgia Study Finds 4/20/2007
More...
|
Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 4/11/2007
More...
|
Xanthus Pharmaceuticals, Inc. Acquires from Johns Hopkins University Exclusive License to Patent Estate Covering FLT3 Pathway as a Target for Treating Autoimmune Diseases 4/11/2007
More...
|
Minnesota Partnership Researchers Discover Disease 'Fingerprint' 4/5/2007
More...
|
MediStem Laboratories, Inc. Commences Pre-Clinical Research With Lawson Health Research Institute in London, Ontario in the Treatment of Autoimmune Diseases 3/27/2007
More...
|
Schizophrenia Gene May Be Linked to Inflammation: Study 3/21/2007
More...
|
Accentia Biopharmaceuticals (ABPI) Acquires Worldwide Exclusive License to Revimmune for All Autoimmune Diseases 2/28/2007
More...
|
Scientists Learn The Origin Of Rogue B Cells 2/8/2007
More...
|
China Biopharma Inc. (CBPC.OB) Expands Product Line To Treat Autoimmune Diseases 2/5/2007
More...
|
China Biopharma Inc. (CBPC.OB) Expands Product Line To Treat Autoimmune Diseases 2/5/2007
More...
|
Whitehead Institute And The Dana-Farber Cancer Institute Have Identified A Key Set Of Genes That Lie At The Core Of Autoimmune Disease 1/22/2007
More...
|
New Lab Mouse To Help Study Increased Risk Of Autoimmune Inflammatory Diseases In Women 12/29/2006
More...
|
Pharmacyclics, Inc. (PCYC) Announces Preclinical Data Publication Indicating Potential Use Of Its Novel Selective B-Cell Tyrosine Kinase Inhibitor Compounds In Autoimmune Diseases And Lymphomas 12/14/2006
More...
|
Protalex, Inc. (PRTX) Lead Compound, PRTX-100, Inhibits Platelet Phagocytosis In Vitro 12/11/2006
More...
|
Molecule Linked To Autoimmune Disease Relapses Identified At Stanford University Medical Center 12/4/2006
More...
|
MultiCell Technologies Inc. (MCET.OB) Obtains Patent Protection In Several European Countries For Treatment Of Autoimmune Diseases 11/29/2006
More...
|
Autoimmune Disease Triggered If T Cells Miss A Single Protein Early On 11/22/2006
More...
|
T For two: Scientists Show How Immune System Chooses Best Way To Fight Infection 11/14/2006
More...
|
Data From Pre-Clinical Study Of Protalex, Inc. (PRTX)'s PRTX-100 Compound To Be Presented At The Fifth International Conference On Autoimmunity In Sorrento, Italy 11/14/2006
More...
|
Idera Pharmaceuticals, Inc. (IDP) Presents Preclinical Data On Novel Class Of Toll-Like Receptor Antagonists 11/10/2006
More...
|
Lexicon Genetics Incorporated (LEXG) Initiating IND-Enabling Studies For LX2931 For Autoimmune Disease 10/17/2006
More...
|
MultiCell Technologies Inc. (MCET.OB) Announces Milestone Patent Issued By European Patent Office On Treatments For Autoimmune Diseases 10/13/2006
More...
|
Data From Protalex, Inc. (PRTX)'s Phase I Clinical Trial Of PRTX-100 Presented At The American College Of Clinical Pharmacology 10/9/2006
More...
|
Amgen (AMGN) To Acquire Avidia, Inc., A Privately Held Biopharmaceutical Company In The San Francisco Bay Area; $290 Million Cash 9/29/2006
More...
|
Whatman Plc Protein Biochip Receives CE Registration For Diagnosis Of Autoimmune Diseases 9/26/2006
More...
|
Alba Therapeutics Corporation Announces Phase II Trial For Zonulin Antagonist AT-1001 9/21/2006
More...
|
New Cell-Based Targets For Treating Autoimmune Inflammatory Diseases 8/31/2006
More...
|
Predix Pharmaceuticals Announces Collaboration For Development Of S1P1 Modulators For The Treatment Of Autoimmune Diseases With Amgen (AMGN); Total Payments To Predix Could Exceed $300 Million 7/31/2006
More...
|
Actelion Ltd. (ALIOF.PK) And Roche (RHHBY) Enter Into Autoimmune Disorder Collaboration; Actelion To Receive Upfront Payment Of $75 Million 7/17/2006
More...
|
VLST Corp. Raises $55 Million Series B Financing 6/16/2006
More...
|
Aspreva Pharmaceuticals Corporation (ASPV) And Roche (RHHBY) Receive Orphan Drug Designation From FDA For Evaluation Of CellCept In Rare Autoimmune Disease Pemphigus Vulgaris 6/6/2006
More...
|
New Pathways For Autoimmune Treatment Identified 5/30/2006
More...
|
Debiopharm S.A. And TcLand S.A. Sign R&D And Exclusive License Option For The Development Of sc28AT In Autoimmune Diseases And Transplantation 5/22/2006
More...
|
MultiCell Technologies Inc. (MCET.OB) To Present Company's Lead Drug Candidates At Equities Magazine Investor Conference 4/21/2006
More...
|
Astellas Pharma Inc., Immuno-Biological Laboratories Conclude Licensing Agreement For Anti-Human Osteopontin Antibody 3/27/2006
More...
|
Pittsburgh Life Sciences Greenhouse Invests $100,000 In StageMark To Help In The Diagnosis And Monitoring Of Lupus And Autoimmune Diseases 3/21/2006
More...
|
Argos Therapeutics, Inc. And Novo Nordisk A/S (NVO) Announce Agreement To Develop Treatment For Systemic Autoimmune Disorders; Argos To Receive Up To $69 Million 3/14/2006
More...
|
Mystery Solved: Gold's Power Against Autoimmune Diseases Defined 2/27/2006
More...
|
Pharmos Corporation (PARS) Completes Phase I Cannabinor Study 1/27/2006
More...
|
Medarex, Inc. (MEDX) Announces NovImmune SA Filing Of Investigational New Drug Application For Fully Human Antibody For The Treatment Of Autoimmune Disease 1/19/2006
More...
|
Galapagos Genomics NV Enters New Collaboration In Autoimmune Discovery Research 1/16/2006
More...
|
Infection-Fighting Protein Could Be Key To Autoimmune Disease, Say University of Michigan Scientists 1/11/2006
More...
|
Alba Therapeutics Corporation Announces Upcoming Trials In Celiac Disease And The Appointment Of Richard DiMarchi To Its Board Of Directors 12/23/2005
More...
|
Biocryst Pharmaceuticals (BCRX) And Roche (RHHBY) Licensing Deal Wins Early Approval From FTC 12/22/2005
More...
|
Scientists Discover New Cellular Structures 12/8/2005
More...
|
TolerRx, Inc. Initiates Three Clinical Trials In Autoimmune Indications 12/7/2005
More...
|
Roche (RHHBY) And Biocryst Pharmaceuticals (BCRX) Collaborate On Clinical Compound BCX-4208 For Transplantation And Autoimmune Diseases; Agreement Worth Up To $530 Million 11/30/2005
More...
|
Bio-Rad Laboratories, Inc. (BIO) Receives FDA Clearance For Novel Interpretive Software Used For Autoimmune Testing 11/16/2005
More...
|
Immunomedics, Inc. (IMMU) Reports Updated Clinical Results For Epratuzumab In Sjogren's Syndrome At The 2005 ACR/ARHP Annual Scientific Meeting 11/15/2005
More...
|
Alba Therapeutics Corporation And The University of Maryland Report The Role Of Zonulin And Intestinal Permeability in Celiac Disease 11/4/2005
More...
|
Alba Therapeutics Corporation Announces Completion Of First Human Trial For AT-1001 And FDA "Fast Track" Designation 10/26/2005
More...
|
Mechanism Behind Autoimmune Diseases Found 10/24/2005
More...
|
Alba Therapeutics Corporation Announces Phase I Trial For Zonulin Antagonist AT-1001 9/27/2005
More...
|
MedImmune, Inc. (MEDI) To Buy Cellective Therapeutics 9/14/2005
More...
|
LIAI Scientists Discover Cellular Switch For Controlling Immune System Function 9/12/2005
More...
|
MultiCell Technologies Inc. (MUCL.OB) Forms New Company To Develop Novel Therapies For Diabetes And Other Autoimmune Diseases 9/8/2005
More...
|
Dynex Technologies Partners With The Binding Site To Provide Automated And Validated Systems For Autoimmune And Infectious-Disease Assays, As Well As 24/7 Service And Support 8/2/2005
More...
|
Promising Treatment for Juvenile Diabetes Advances With Agreement Signed By MacroGenics Inc. And Tolerance Therapeutics 7/18/2005
More...
|
Amarillo Biosciences (AMAR) Low-Dose Oral Interferon Study With NOBEL To Treat Behcet's Disease Clears FDA Review Process 7/12/2005
More...
|
Kalypsys, Inc. And NovImmune SA Establish Collaboration For Discovery And Development Of New Drugs For Autoimmune And Inflammatory Diseases 6/16/2005
More...
|
Immunomedics, Inc. (IMMU) Awarded U.S. And Australian Patents For Autoimmune Disease Therapy With CD22 Antibodies 6/16/2005
More...
|
Illumina, Inc. (ILMN) Launches Industry's First SNP Assay Panels For Fine Mapping Disease-Associated Genetic Variants In The Major Histocompatability Complex -MHC- Region Of The Genome 6/7/2005
More...
|
GammaCan International, Inc. (GCAN.OB) Appoints Vered Caplan Acting Chief Executive Officer; Seasoned Business Development Professional To Take Helm As Phase II Trial Continue 6/6/2005
More...
|
Altus Pharmaceuticals Inc. Announces Completion Of Clinical Testing In The Phase I Study Of ALTU-238, A Long-Acting Crystalline Formulation Of Human Growth Hormone 6/6/2005
More...
|
Praecis Pharmaceuticals Incorporated (PRCS) Announces Strategic Restructuring And Refocusing Of Company Operations; Cuts Work Force By 60 Percent To Reduce Costs, Halts Plenaxis Cancer Drug Promotion; Suspend Ongoing Clinical Development Of Apan 5/20/2005
More...
|
Serono International S.A. (SRA) And NovImmune SA To Collaborate In Development Of Two Novel Treatments For Autoimmune Diseases; Up To $105 Million 5/17/2005
More...
|
CEL-SCI (CVM) Announces Presentation Of Data Showing Significant Reduction In Incidence And Severity Of Autoimmune Myocarditis 5/16/2005
More...
|
Cellerant Therapeutics, Inc. Raises $16 Million To Advance Stem Cell-Based Therapies For Life-Threatening Diseases; Series B proceeds To Fund Cancer, Sickle Cell And Autoimmune Programs 5/11/2005
More...
|
Repligen Corporation (RGEN) Announces Settlement Of SecreFlo(TM) Arbitration 5/10/2005
More...
|
Serono, Inc. (SRA) And Genmab A/S (GNMSF.PK) Sign Worldwide Agreement To Develop And Commercialize HuMax-TAC; Up To USD 38 Million 5/2/2005
More...
|
ParAllele Bioscience, Inc. Collaborates With Both University of Southern California And Baylor University On Large-Scale Association Studies Of Lupus And Respiratory Pathogens 4/27/2005
More...
|
Medarex, Inc. (MEDX) Announces Upcoming Presentations At American Association for Cancer Research Meeting 4/14/2005
More...
|
Domantis Limited In Licence Deal With Tanox 3/23/2005
More...
|
Stratagene Announces FDA Clearance Of Additional Autoimmune Test; Hycor Biomedical Autoimmune Portfolio Now At 32 3/21/2005
More...
|
FDA Warns Biogen Idec, Inc. Over Multiple Sclerosis Drug 3/17/2005
More...
|
Medarex, Inc. (MEDX) And Bristol-Myers Squibb Company (BMY) Announce Complete And Partial Responses Observed In Phase I/II Clinical Study Of MDX-010 In Combination With Il-2 3/7/2005
More...
|
Medical Marketing International Group plc (MMG.L) To License Auto-Immune Treatment From London Colleges 3/4/2005
More...
|
La Jolla Institute for Allergy & Immunology Scientists Make Important Finding On Regulation Of Immune Cell Memory; Research Could Lead To Future Treatment Advances For Cancer, AIDS And Autoimmune Diseases 3/3/2005
More...
|
Avidex Limited Technology Yields Novel Immunotherapeutic Protein Platform 3/1/2005
More...
|
Cobra BioManufacturing (CBF.L) Signs Long Term Deal With Neovacs SA To Supply Phase I Clinical Trial Material For A Novel Protein Active Immunization Therapy: TNFa Kinoid 2/25/2005
More...
|
Scleroderma Foundation Awards One Million Dollars In New Research Grants 2/25/2005
More...
|
Protein Design Labs, Inc. (PDLI) Announces Ruling In European Patent Opposition Proceeding 2/3/2005
More...
|
Argos Therapeutics, Inc. Receives $1.0 Million Grant For Lupus Research; ALR Funding To Support Antibody Research 2/2/2005
More...
|
Musks In Fragrances May Weaken Immune System, Study Says 1/10/2005
More...
|
Chamomile Tea May Have Medicinal Value 1/10/2005
More...
|
Dynavax Technologies Corporation (DVAX) Debuts Novel IRS Technology: New Platform For Autoimmune Disease Drug Discovery 1/10/2005
More...
|
Sunesis Pharmaceuticals, Inc. Announces Extension Of Collaboration With Johnson & Johnson Pharmaceutical Research & Development 1/10/2005
More...
|
Elan Corporation PLC (ELN) And Roche (RHHBY) Expand Nanocrystal Technology License 1/7/2005
More...
|
Bio-Rad Laboratories, Inc. (BIO) Receives FDA Clearance For New BioPlex(R) 2200 System 1/3/2005
More...
|
Micromet And EvoGenix Pty Ltd Sign License Agreement For Single-Chain Antibodies 12/23/2004
More...
|
MedImmune, Inc. (MEDI) And Medarex, Inc. (MEDX) Announce Collaboration To Develop And Commercialize Fully Human Antibodies For Autoimmune Diseases 11/23/2004
More...
|
Medarex, Inc. (MEDX) To Host Conference Call Today To Discuss MedImmune Vaccines, Inc. Development And Commercialization Collaboration For Fully Human Antibodies For Autoimmune Diseases 11/23/2004
More...
|
Vaccinex, Inc. And Biocon To Co-Develop Antibody Products 11/18/2004
More...
|
Viral Genetics Inc. (VRAL) Completes Private Placement; Raises $2 Million 11/18/2004
More...
|
Medarex, Inc. (MEDX) To Host Conference Call Today To Discuss Bristol-Myers Squibb Company (BMY) Development And Commercialization Collaboration For MDX-010 11/8/2004
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Describes New Data With Potent Second Generation Immune Regulating Hormones In Preclinical Models Of Autoimmune And Inflammatory Conditions 11/4/2004
More...
|
La Jolla Institute for Allergy & Immunology Scientists Make Important Finding On Virus' Role In Autoimmune Diseases 11/2/2004
More...
|
Gene-altered Mouse Is Model For Rare Autoimmune Syndrome 10/21/2004
More...
|
Metaphore Pharmaceuticals, Inc. To Present At Pain Therapeutics Conference 10/21/2004
More...
|
Active Biotech AB's Capital Market Meeting With Teva Pharmaceutical Industries Limited (TEVA) In Stockholm On October 19 10/18/2004
More...
|
MacroGenics Inc. Completes Series B Financing; $30.5 Million 10/15/2004
More...
|
PharmaFrontiers Acquires Multiple Sclerosis Cell Therapy Developer Opexa Pharmaceuticals, Inc. 10/8/2004
More...
|
Illumina, Inc. (ILMN) To Conduct Large-Scale Genotyping Study For North American Rheumatoid Arthritis Consortium 9/16/2004
More...
|
Nautilus Biotech And Creabilis Therapeutics Enter Collaboration Agreement On Novel Therapeutic Protein 9/3/2004
More...
|
ZymoGenetics (ZGEN) Announces Start Of TACI-Ig Clinical Study In Rheumatoid Arthritis; Second Phase 1b Study Initiated In Patients With Autoimmune Disease 8/30/2004
More...
|
Roche (RHHBY) Release: New Perspectives In The Fight Against Autoimmunity 8/23/2004
More...
|
Research On Metaphore Pharmaceuticals, Inc.'s Lead Pain Management Drug Candidate Published In The Journal Of Pharmacology And Experimental Therapeutics 8/2/2004
More...
|
CBio Limited Gears Up For Phase II Trials Of Autoimmune Drug 7/27/2004
More...
|
ZymoGenetics (ZGEN) Announces Start Of TACI-Ig Clinical Study In Lupus Patients; Phase 1b Study In Autoimmune Disease With Unmet Medical Needs 7/27/2004
More...
|
Trubion Pharmaceuticals Inc. Raises $32 Million In Series B Financing To Fund Advancement Of Lead Product Candidates 7/14/2004
More...
|
Damaged Mouse Immune System Can't Stop Escape Of Mutating Virus 6/17/2004
More...
|
Hormonal Clue To Autoimmune Diseases Found 6/4/2004
More...
|
Researchers Reveal That Microbes Have Stolen Some Of Our Genes 5/26/2004
More...
|
New Jackson Laboratory Research Findings Suggest Therapeutic Approach for Combating Autoimmune Diseases 5/4/2004
More...
|
Metaphore Pharmaceuticals, Inc. Announces Positive Results Of Phase II Clinical Trial 4/27/2004
More...
|
Super-Antibodies To Fight Disease 4/26/2004
More...
|
Mothers' Cells Can Cause Immunity Illness In Children 4/26/2004
More...
|
Protein May Help Prevent Autoimmune Attacks 4/26/2004
More...
|
Metaphore Pharmaceuticals, Inc. To Present New Phase II Clinical Data At CIBC World Markets Annual Biotechnology And Specialty Pharmaceuticals Conference 4/21/2004
More...
|
Merrimack Pharmaceuticals Inc. Awarded Second SBIR Grant 3/25/2004
More...
|
Lupus Discovery May Pave Way To Better-Designed COX-2 Inhibitors 3/18/2004
More...
|
MorphoSys AG Enters New Antibody Program With Centocor, Inc. (JNJ) 3/8/2004
More...
|
Compugen (CGEN) Discovers Novel Soluble CD40 Protein; Company CEO Describes Discovery Engine Capability At R&D Leaders' Forum 3/1/2004
More...
|
Diagnostic Product From SmartBead Technologies Ltd. Successfully Beta Tested 2/12/2004
More...
|
Celltech Group PLC (CLL) And Biogen Idec, Inc. (Massachusetts) (BGEN) Announce Autoimmune Disease Collaboration 2/5/2004
More...
|
Xencor Determines Structure Of BAFF, A Key Autoimmune Disease Target; Discovery Enables Dominant Negative Inhibitor Strategy And Clarifies BAFF Structural Controversy 1/29/2004
More...
|
Sunesis Pharmaceuticals Announces Extension Of Small Molecule Collaboration With Johnson and Johnson Pharmaceutical R&D (CA) 1/15/2004
More...
|
GMP Companies, Inc. Enters Into Agreement With The University of Michigan To Develop Therapies For Autoimmune Diseases 12/11/2003
More...
|
Immunomedics, Inc. (IMMU) Highlights Advances In Its Therapeutic Pipeline At 2003 Annual Meeting Of Shareholders 12/3/2003
More...
|
La Jolla Pharmaceutical Company (LJPC) Discovers Small Molecule That Produces Positive Results In Autoimmune Disease And Inflammation Models 12/2/2003
More...
|
Gamida Cell Ltd. Pre-Clinical Results Show Company Stem Cell Expansion Technology Successful With Serum Free Media; Company Begins Plans To Develop Serum Free StemEx 12/1/2003
More...
|
Merrimack Pharmaceuticals Inc. Completes Dosing In Phase I Study Of Immunomodulator, MM-093 11/19/2003
More...
|